News

FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, ...
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...
GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric emptying - also have a range of other benefits.
As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ensure safety. One such research has shown that it could help prevent cognitive ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...
The research also found that weight-loss medication is boosting men’s dating lives more than women’s. Men were more likely to ...
The soupy, smothering extreme heat that has scorched parts of the Northern Hemisphere this summer takes a hard toll on our ...
Six months ago, I took a leap into the unknown, writes DONAL MACINTYRE. After tipping the scales the other way, here I reveal ...
Common medicines, including diabetes, cancer, and antiviral drugs, may offer new hope in slowing dementia. UK researchers, including a team from the University of Cambridge, have uncovered strong ...